Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Monitoring Cross-Contamination in Gel Manufacturing – V 2.0

Posted on By

Gel Manufacturing: SOP for Monitoring Cross-Contamination in Gel Manufacturing – V 2.0

Standard Operating Procedure for Monitoring Cross-Contamination in Gel Manufacturing

Department Gel Manufacturing
SOP No. SOP/GM/193/2025
Supersedes SOP/GM/193/2022
Page No. Page 1 of 15
Issue Date 10/06/2025
Effective Date 12/06/2025
Review Date 10/06/2027

1. Purpose

To define the procedure for identifying, preventing, monitoring, and documenting cross-contamination events in gel manufacturing processes, in accordance with GMP and regulatory guidelines.

2. Scope

This SOP applies to all stages of gel manufacturing, including material handling, equipment usage, processing, in-process storage, and cleaning, at the Gel Manufacturing facility.

3. Responsibilities

  • Production Chemist: Ensures compliance with prevention measures during manufacturing.
  • QA Officer: Performs periodic monitoring and audits for potential contamination sources.
  • Housekeeping Staff: Follows defined cleaning procedures between product batches.
  • Engineering Department: Maintains air handling systems and equipment integrity.
See also  Gel Manufacturing: SOP for Filtering Gel Formulations Before Filling - V 2.0

4. Accountability

Head – Manufacturing

is accountable for overall implementation of cross-contamination controls and ensuring compliance with the SOP.

5. Procedure

5.1 Identification of Cross-Contamination Risks

  1. Review process flow diagrams for each gel product to identify potential contamination crossover points.
  2. Classify risks based on type: airborne, mechanical, personnel-borne, or equipment-induced.

5.2 Preventive Controls

  1. Implement physical segregation for materials and products with different actives.
  2. Use dedicated equipment for highly sensitizing or potent APIs wherever applicable.
  3. Establish unidirectional personnel and material flow.
  4. Ensure use of color-coded tools, containers, and garments.
  5. Maintain appropriate pressure differentials in processing rooms.

5.3 Environmental Monitoring

  1. Perform regular air sampling and surface swabbing after each product batch.
  2. Monitor microbial load and particulate matter in manufacturing and filling areas.
  3. Maintain records as per Annexure-2 and Annexure-3.

5.4 Cleaning and Line Clearance

  1. Follow validated cleaning procedures for all equipment and surfaces (Refer Annexure-4).
  2. Conduct line clearance using approved checklists.
  3. Record equipment cleaning in the Equipment Cleaning Record (Annexure-5).
See also  Gel Manufacturing: SOP for Labeling and Coding of Gel Products Before Secondary Packing - V 2.0

5.5 Investigation of Cross-Contamination Events

  1. Initiate deviation report for any suspected contamination.
  2. Conduct root cause analysis (RCA) using Ishikawa diagram or 5-Why technique.
  3. Implement CAPA and document in QA logs.

6. Abbreviations

  • API: Active Pharmaceutical Ingredient
  • RCA: Root Cause Analysis
  • CAPA: Corrective and Preventive Action
  • GMP: Good Manufacturing Practice

7. Documents

  1. Cross-Contamination Monitoring Log – Annexure-1
  2. Air Sampling Log – Annexure-2
  3. Surface Swab Testing Record – Annexure-3
  4. Cleaning Checklist – Annexure-4
  5. Equipment Cleaning Record – Annexure-5

8. References

  • WHO TRS 986 Annex 2: Cross-contamination in manufacturing
  • EU GMP Chapter 5: Production
  • Schedule M: Good Manufacturing Practices for Pharmaceuticals

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing
See also  Gel Manufacturing: SOP for Conducting Supplier Audits for Raw Materials - V 2.0

11. Annexures

Annexure-1: Cross-Contamination Monitoring Log

Date Area Product Observation Corrective Action Checked By

Annexure-2: Air Sampling Log

Date Room No. Sampling Time CFU Count Limit Reviewed By
Max 100 CFU/m³

Annexure-3: Surface Swab Testing Record

Date Location Sample ID CFU Count Limit Reviewed By
NMT 5 CFU/swab

Annexure-4: Cleaning Checklist

Equipment Cleaned By Date Time Verified By Remarks

Annexure-5: Equipment Cleaning Record

Equipment ID Product Last Used Cleaned On Cleaning Method Verified By Remarks
Manual/Automated

Revision History

Revision Date Revision No. Change Description Reason Approved By
01/06/2022 1.0 Initial version New SOP implementation QA Head
10/06/2025 2.0 Included monitoring formats and specific equipment record Annual review QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: Inconsistencies Between Process Validation SOPs and Actual Practices: A Critical GMP Concern
Next Post: Elixir Department: SOP for Alcohol Content Estimation (Intermediate) – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version